Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - REGENXBIO Inc. | rgnx-ex321_129.htm |
| EX-31.2 - EX-31.2 - REGENXBIO Inc. | rgnx-ex312_130.htm |
| EX-31.1 - EX-31.1 - REGENXBIO Inc. | rgnx-ex311_131.htm |
| EX-21.1 - EX-21.1 - REGENXBIO Inc. | rgnx-ex211_133.htm |
| EX-10.42 - EX-10.42 - REGENXBIO Inc. | rgnx-ex1042_134.htm |
| EX-10.5 - EX-10.5 - REGENXBIO Inc. | rgnx-ex105_135.htm |
| EX-10.4 - EX-10.4 - REGENXBIO Inc. | rgnx-ex104_136.htm |
| EX-4.2 - EX-4.2 - REGENXBIO Inc. | rgnx-ex42_137.htm |
| 10-K - 10-K - REGENXBIO Inc. | rgnx-10k_20201231.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-226691) and Form S-8 (No. 333-229910, 333-223466, 333-216508, 333-209899, 333-206984, 333-236664) of REGENXBIO Inc. of our report dated March 1, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Arlington, Virginia
March 1, 2021
1